【艾美疫苗午前股价上涨 6.93%，现报 3.86 港元，成交额 697.40 万港元】艾美疫苗发布公告，其研发的 mRNA 带状疱疹疫苗继 2025 年 3 月获美国食品和药品监督管理局批准开展临床试验后，近日又获国家药品监督管理局《药物临床试验批准通知书》。 目前国际上尚无 mRNA 带状疱疹疫苗获批上市，国内接种率不到 1%。预计到 2030 年，中国市场规模约 200 亿元，全球约 239...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.